CytomX Therapeutics, Inc. Shares Authorized
CytomX Therapeutics, Inc. (CTMX) had Shares Authorized of 300.00 million shares as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-03-16
- 2025-12-31: Common Stock, Shares Authorized 300.00M shares.
- 2024-12-31: Common Stock, Shares Authorized 150.00M shares; Common Stock, Shares Authorized as first filed 300.00M shares.
- 2023-12-31: Common Stock, Shares Authorized 150.00M shares.
- 2022-12-31: Common Stock, Shares Authorized 150.00M shares.
| Period end | Common Stock, Shares Authorized | Common Stock, Shares Authorized as first filed |
|---|---|---|
| 2025-12-31 | 300.00M shares 10-K · filed 2026-03-16 | |
| 2024-12-31 | 150.00M shares 10-K · filed 2026-03-16 | 300.00M shares 10-K · filed 2025-03-06 |
| 2023-12-31 | 150.00M shares 10-K · filed 2025-03-06 | |
| 2022-12-31 | 150.00M shares 10-K · filed 2024-03-11 | |
| 2022-09-30 | 150.00M shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 150.00M shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | 150.00M shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 150.00M shares 10-K/A · filed 2023-03-27 | |
| 2021-09-30 | 150.00M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 150.00M shares 10-Q · filed 2021-08-05 | |
| 2021-03-31 | 150.00M shares 10-Q · filed 2021-05-06 | |
| 2020-12-31 | 150.00M shares 10-K/A · filed 2023-03-27 | |
| 2020-09-30 | 150.00M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 150.00M shares 10-K · filed 2021-02-24 | |
| 2020-05-31 | 75.00M shares 10-Q · filed 2020-11-05 | |
| 2020-03-31 | 75.00M shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 75.00M shares 10-K · filed 2021-02-24 | |
| 2019-09-30 | 75.00M shares 10-Q · filed 2019-11-07 | |
| 2019-06-30 | 75.00M shares 10-Q · filed 2019-08-07 | |
| 2019-03-31 | 75.00M shares 10-Q · filed 2019-05-09 | |
| 2018-12-31 | 75.00M shares 10-K · filed 2020-02-27 | |
| 2018-09-30 | 75.00M shares 10-Q · filed 2018-11-06 | |
| 2018-06-30 | 75.00M shares 10-Q · filed 2018-08-08 | |
| 2018-03-31 | 75.00M shares 10-Q · filed 2018-05-09 | |
| 2017-12-31 | 75.00M shares 10-K · filed 2019-02-27 | |
| 2017-09-30 | 75.00M shares 10-Q · filed 2017-11-07 | |
| 2017-06-30 | 75.00M shares 10-Q · filed 2017-08-07 | |
| 2017-03-31 | 75.00M shares 10-Q · filed 2017-05-05 | |
| 2016-12-31 | 75.00M shares 10-K · filed 2018-03-07 | |
| 2016-09-30 | 75.00M shares 10-Q · filed 2016-11-03 | |
| 2016-06-30 | 75.00M shares 10-Q · filed 2016-08-03 | |
| 2016-03-31 | 75.00M shares 10-Q · filed 2016-05-06 | |
| 2015-12-31 | 75.00M shares 10-Q · filed 2016-11-03 | |
| 2015-12-10 | 75.00M shares 10-K · filed 2017-03-02 | |
| 2015-10-14 | 75.00M shares 10-K · filed 2021-02-24 | |
| 2015-09-30 | 36.20M shares 10-Q · filed 2015-11-23 | |
| 2014-12-31 | 28.57M shares 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |